Comparison of Two Pulse Oximeters in Delivery Room
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02704585|
Recruitment Status : Unknown
Verified March 2016 by Bromiker, Ruben M.D, Shaare Zedek Medical Center.
Recruitment status was: Recruiting
First Posted : March 10, 2016
Last Update Posted : March 10, 2016
|Condition or disease||Intervention/treatment||Phase|
|Hypoxia||Device: Nellcor Device: Masimo||Not Applicable|
After delivery babies will be located in the radiant warmer. The probe of each pulse oximeter will be applied to one of the feet. Both probes will be simultaneously connected to the female plug of the pulse oximeter.
Heart rate will be checked
Time to get a stable reading in each device (by observation on the devices' display) will be recorded; this will be the primary study outcome. Other vital signs (oxygen saturation, heart rate) and demographics) will be recorded as well.
Paired students T test will be used for the statistical analyzes.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Comparison of Two Pulse Oximeters in Delivery Room: A Prospective Study|
|Study Start Date :||January 2016|
|Estimated Primary Completion Date :||January 2017|
|Estimated Study Completion Date :||January 2017|
Connection to Nellcor pulse oximeter for measuring oxygen saturation after birth
Measurement of pulse oximetry in the delivery room with Nellcor pulse oximeter
Connection to Masimo pulse oximeter for measuring oxygen saturation after birth
Measurement of pulse oximetry in the delivery room with Masimo pulse oximeter
- Time to steady reading in the pulse oximeter [ Time Frame: up to 2 minutes ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02704585
|Contact: Yakir Shir, MDfirstname.lastname@example.org|
|Jerusalem, Israel, 91031|
|Contact: Ruben Bromiker, MD 972508685154 email@example.com|
|Contact: Yakir Shir, MD 972523121040 firstname.lastname@example.org|
|Study Chair:||Ruben Bromiker, MD||Shaare Zedek Medical Center|